Skip to content

Group Versus Individual Care in Diabetes Clinic

Group Versus Individual Care in Patients With Long Standing Type 1 and Type 2 Diabetes: Non Inferiority in a One Year Prospective Study in a Tertiary Diabetes Clinic

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03353376
Enrollment
60
Registered
2017-11-27
Start date
2010-09-13
Completion date
2014-01-02
Last updated
2017-11-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus, Group Meetings

Brief summary

In this prospective, randomized, non blinded, one center (University hospital) trial, 60 patients (28 with type 1 and 32 with type 2 diabetes) with a mean duration of diabetes of 22.5 ± 11.7 years were randomly assigned to group (6 patients per group) or individual usual care for one year. Primary end-point included change in Hba1c and visits to out-patients clinics, secondary endpoint included change in body mass index, blood pressure levels, waist circumference, non HDL Cholesterol, diabetes related and quality of life questionnaires and hospitalizations.

Detailed description

in the intervention arm patients attended 4 preplanned group visits in the study year and the empowerment model was used in the group care visits.

Interventions

BEHAVIORALgroup care with Empowerment model

Patients with type 2 and type 1 diabetes were followed in a tertiary outpatient clinic with group appointment

Sponsors

Rabin Medical Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Diagnosis of type 1 or type 2 diabetes * Fluency in Hebrew * Attendance at least for the second time at the diabetes clinic * Follow up of at least one year by a general practitioner * Willingness to participate in the study and to give informed consent.

Exclusion criteria

* Uncontrolled psychiatric diseases * Active cancer * Pregnancy

Design outcomes

Primary

MeasureTime frameDescription
change in in Hba1c levelsone year from date of randomizationCollection of data at start and after one year

Secondary

MeasureTime frameDescription
change in non HDL Cholesterolone year from date of randomizationCollection of data at start and end of study from electronic files
change in scores of diabetes specific questionnaireone year from date of randomizationCollection of data at start and end of study from electronic files
change in BMI in kg/m2one year from date of randomizationCollection of data (weight in kg, height in meter) at start and end of study from electronic files

Other

MeasureTime frameDescription
change in number of outpatients visitsone year from date of randomizationCollection of data at start and after one year
change in number in hospital admissionone year from date of randomizationCollection of data at start and end of study from electronic files

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026